Unibest

Pharmaceutical intermediates

Baloxavir Marboxil Intermediates

4 pharmaceutical intermediates for Baloxavir Marboxil. Indication: Influenza A Virus Infection; Influenza Virus Infection; Influenza B Virus Infection.

提交项目All intermediates

About Baloxavir Marboxil

Originator
Shionogi & Co., Ltd.
Indication
Influenza A Virus Infection; Influenza Virus Infection; Influenza B Virus Infection
Approved Date
10/24/2018
DS/DP
06/14/2030

Available intermediates

4 intermediates currently listed for Baloxavir Marboxil. Request specifications, documentation or a quotation for any item below.

Baloxavir Marboxil intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
N-[2-[[[2-(2,2-dimethoxyethoxy)ethyl]amino]carbonyl]-4-oxo-3-(phenylmethoxy)-1(4H)-pyridinyl]-Carbamic acid 1,1-dimethylethyl ester2136287-61-9//
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione1985607-70-2//
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol1985607-83-7//
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione1370250-39-7//

Other programs under B

BaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBeraprost SodiumBictegravir

Building toward Baloxavir Marboxil?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →